Navibact

Navibact is a ceftazidime and avibactam combination for resistant gram-negative infections including urinary tract and intra-abdominal infections.

Type:

Injection

Classification:

Antibiotic

#CEFTAZIDIME #AVIBACTAM #ANTIBIOTIC #GRAM-NEGATIVE #RESISTANT

Navibact Product Image

Product Overview

Navibact is a novel combination of cephalosporin and β-lactamase inhibitor for treatment of multidrug-resistant gram-negative infections.

Composition

  • Ceftazidime - third-generation cephalosporin
  • Avibactam - β-lactamase inhibitor

Indications

  • Complicated urinary tract infections
  • Intra-abdominal infections
  • Resistant Pseudomonas aeruginosa infections
  • Extended-spectrum β-lactamase producing organisms
  • Healthcare-associated infections

Marketed By

Vee Medi Biotech